Global Heart Scan Market to Surpass USD 18,533.07 Million by 2031 | CAGR of 6.3%
Category : Healthcare | Published Date : Nov 2024 | Type : Press Release
Heart Scan Market Scope & Overview:
In the newly published report, Consegic Business Intelligence states that the Heart Scan Market was valued at USD 11,344.62 Million in 2023 and is projected to reach USD 18,533.07 Million by 2031, growing at a CAGR of 6.3% from 2024 to 2031. A heart scan, or coronary calcium scan, is a specialized imaging test that utilizes computed tomography (CT) technology to detect and measure the extent of calcified plaque in the coronary arteries. This non-invasive procedure aids in assessing the risk of coronary artery disease (CAD), providing early detection and enabling tailored treatment plans.
The report comprises the Heart Scan Market Share, Size & Industry Analysis, By Type (Echocardiogram (ECG), Electron Beam Computed Tomography (EBCT), Nuclear Heart Scan, Angiocardiography, Cardiac Catheterization, Coronary Arteriography, Others), By Indication (Coronary Artery Blockage, Congenital Heart Disease, Blood Clots, Tumors, Others), By End-User (Medical Laboratories, Research Institutes, Hospitals & Clinics, Specialty Cardiac Centers, Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), and Forecast, 2024–2031.
The report contains detailed information on Heart Scan Market Trends, Opportunities, Value, Growth Rate, Segmentation, Geographical Coverage, Company Profile, In-depth Expert Analysis, Revenue Forecast, Competitive Landscape, Growth Factors, Restraints or Challenges, Environment & Regulatory Landscape, PESTLE Analysis, PORTER Analysis, Key Technology Landscape, Value Chain Analysis, and Cost Analysis.
Rising adoption of preventive cardiology measures and advancements in imaging technologies are key drivers, while high procedure costs and limited accessibility in certain regions remain restraints.
Segmental Analysis :
By Type, the market is segmented into Echocardiogram (ECG), Electron Beam Computed Tomography (EBCT), Nuclear Heart Scan, Angiocardiography, Cardiac Catheterization, Coronary Arteriography, and Others.
- Echocardiogram (ECG) held the largest share of 29.87% in 2023, driven by its non-invasive nature and wide availability for diagnosing various cardiovascular conditions.
- Nuclear Heart Scan is expected to register the fastest CAGR, attributed to its detailed functional insights and increasing demand for non-invasive diagnostic tools.
By Indication, the market includes Coronary Artery Blockage, Congenital Heart Disease, Blood Clots, Tumors, and Others.
- Coronary Artery Blockage dominated the market in 2023 due to the high prevalence of coronary artery disease and the critical role of heart scans in early detection.
- Congenital Heart Disease is anticipated to grow at the fastest rate, driven by advances in pediatric cardiology and improved diagnostic capabilities.
By End-User, the market is categorized into Medical Laboratories, Research Institutes, Hospitals & Clinics, and Specialty Cardiac Centers.
- Hospitals & Clinics accounted for the largest share, as they are primary settings for heart scan procedures, equipped with advanced diagnostic tools.
- Specialty Cardiac Centers are expected to grow rapidly, owing to their focus on specialized, high-quality cardiac care and advanced imaging services.
Based on regions, the global market is segmented into North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
- Asia-Pacific is expected to exhibit the highest growth, driven by rising healthcare investments, increasing medical tourism, and the prevalence of cardiovascular diseases.
- North America leads in market share due to advanced healthcare infrastructure, a high incidence of heart diseases, and widespread adoption of innovative imaging technologies.
| Report Attributes | Report Details |
| Study Timeline | 2018-2031 |
| Market Size in 2031 | USD 18,533.07 Million |
| CAGR (2024-2031) | 6.3% |
| By Type | Echocardiogram (ECG), Electron Beam Computed Tomography (EBCT), Nuclear Heart Scan, Angiocardiography, Cardiac Catheterization, Coronary Arteriography, Others |
| By Indication | Coronary Artery Blockage, Congenital Heart Disease, Blood Clots, Tumors, Others |
| By End-User | Medical Laboratories, Research Institutes, Hospitals & Clinics, Specialty Cardiac Centers, Others |
| By Region | North America(U.S., Canada, Mexico) Europe(U.K., Germany, France, Spain, Italy, Russia, Benelux, Rest of Europe) APAC(China, South Korea, Japan, India, Australia, ASEAN, Rest of Asia-Pacific) Middle East & Africa(GCC, Turkey, South Africa, Rest of MEA) LATAM(Brazil, Argentina, Chile, Rest of LATAM) |
Top Key Players & Competitive Landscape :
The competitive landscape highlights key players focusing on product innovation, research and development, and strategic collaborations to strengthen their market position. The analysis covers the strengths, weaknesses, and strategic moves of these companies.
List of prominent players in the Heart Scan Industry:
- Boston Scientific Corporation (United States)
- Coloplast (Denmark)
- Dispocard GmbH (Germany)
- St. Jude Medical (United States)
- Abbott Laboratories (United States)
- Johnson & Johnson (United States)
- Teleflex Incorporated (United States)
- Smiths Medical (United States)
- Edwards Lifesciences Corporation (United States)
- Medtronic Inc. (United States)
- Maquet Medical India Private Limited (India)
- Terumo Medical Corporation (Japan)
Recent Industry Developments :
- In 2023, Siemens launched the Somatom Pro.Pulse, featuring high-resolution cardiac imaging for patients with high heart rates.
- In 2023, Canon introduced the Aquilion One Insight Edition, offering comprehensive heart scans with faster imaging capabilities.
- In 2022, GE Healthcare expanded its AI-driven cardiac imaging solutions, enhancing diagnostic accuracy in heart scans.
